The patient presenting with acute dysentery - A systematic review

Journal of Infection

Volumn 64, Issue 4, 2012, Pages 374-386

  Pfeiffer, Margaret L ^a   DuPont, Herbert L ^a,b,c,d   Ochoa, Theresa J ^b,e  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c St Luke's Episcopal Hospital   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

Azithromycin; Bacterial infections; Dysentery; E. coli; Fecal leukocytes; Infectious colitis; Intestinal infections; Lactoferrin

Indexed keywords

ANTIAMEBIC AGENT; AZITHROMYCIN; CEFTRIAXONE; CIPROFLOXACIN; DIIODOHYDROQUINE; ERYTHROMYCIN; METRONIDAZOLE; PAROMOMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TINIDAZOLE; UNCLASSIFIED DRUG; URTOXAZUMAB; VANCOMYCIN;

ADULT; AEROMONAS; AEROMONAS INFECTION; AMEBIASIS; ANTIMICROBIAL THERAPY; BACTERIAL INFECTION; CAMPYLOBACTER; CAMPYLOBACTERIOSIS; CAUSAL ATTRIBUTION; CHILD; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DEVELOPING COUNTRY; DIAGNOSTIC TEST; DRUG SENSITIVITY; DYSENTERY; ENDEMIC DISEASE; ENTAMOEBA HISTOLYTICA; ESCHERICHIA COLI INFECTION; FECES ANALYSIS; HUMAN; INCIDENCE; MICROORGANISM DETECTION; MORBIDITY; NONHUMAN; PLESIOMONAS; PLESIOMONAS INFECTION; REVIEW; RURAL AREA; SALMONELLA; SALMONELLOSIS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; SHIGA TOXIN PRODUCING ESCHERICHIA COLI INFECTION; SHIGELLA; SHIGELLOSIS; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; URBAN AREA; VIBRIO; VIBRIOSIS; YERSINIA ENTEROCOLITICA; YERSINIOSIS;

ACUTE DISEASE; ADULT; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; DIARRHEA; DYSENTERY; FECES; HUMANS; LEUKOCYTE COUNT;

EID: 84858622268     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.01.006     Document Type: Review

References (101)

1. Mead P.S., Slutsker L., Dietz V., McCaig L.F., Bresee J.S., Shapiro C., et al. Food-related illness and death in the United States. Emerg Infect Dis 1999, 5(5):607-625.
2. DuPont H.L. Clinical practice. Bacterial diarrhea. N Engl J Med 2009, 361(16):1560-1569.
3. Garcia C., Samalvides F., Vidal M., Gotuzzo E., Dupont H.L. Epidemiology of Clostridium difficile associated diarrhea in a Peruvian Tertiary care hospital. Am J Trop Med Hyg 2007, 77(5):802-805.
4. Talan D., Moran G.J., Newdow M., Ong S., Mower W.R., Nakase J.Y., et al. Etiology of bloody diarrhea among patients presenting to United States emergency departments: prevalence of E. coli O157:H7 and other enteropathogens. Clin Infect Dis 2001, 32(4):573-580.
5. Gui L., Subramony C., Fratkin J., Hughson M.D. Fatal enteritis necroticans (pigbel) in a diabetic adult. Mod Pathol 2002, 15(1):66-70.
6. Gwavava C., Chihota V.N., Gangaidzo I.T., Gumbo T. Dysentery in patients infected with human immunodeficiency virus in Zimbabwe: an emerging role for Schistosoma mansoni and E. coli O157?. Ann Trop Med Parasitol 2001, 95(5):509-513.
7. Pitman C., Amali R., Kanyerere H., Siyasiya A., Phiri S., Phiri A., et al. Bloody diarrhoea of adults in Malawi: clinical features, infectious agents, and antimicrobial sensitivities. Trans R Soc Trop Med Hyg 1996, 90(3):284-287.
8. Bessa S.M., Helmy I., Mekky F., Hamam S.M. Colorectal schistosomiasis: clinicopathologic study and management. Dis Colon Rectum 1979, 22(6):390-395.
9. Kosek M., Yori P.P., Pan W.K., Olortegui M.P., Gilman R.H., Perez J., et al. Epidemiology of highly endemic multiply antibiotic-resistant shigellosis in children in the Peruvian Amazon. Pediatrics 2008, 122(3):e541-e549.
10. Dediste A., Vandenberg O., Vlaes L., Ebraert A., Douat N., Bahwere P., et al. Evaluation of the ProSpecT Microplate Assay for detection of Campylobacter: a routine laboratory perspective. Clin Microbiol Infect 2003, 9(11):1085-1090.
11. Oberhelman R.A., Gilman R.H., Sheen P., Cordova J., Taylor D.N., Zimic M., et al. Campylobacter transmission in a Peruvian shantytown: a longitudinal study using strain typing of Campylobacter isolates from chickens and humans in household clusters. J Infect Dis 2003, 187(2):260-269.
12. Hedican E.B., Medus C., Besser J.M., Juni B.A., Koziol B., Taylor C., et al. Characteristics of O157 versus non-O157 Shiga toxin-producing E. coli infections in Minnesota, 2000-2006. Clin Infect Dis 2009, 49(3):358-364.
13. Kappeli U., Hachler H., Giezendanner N., Beutin L., Stephan R. Human infections with non-O157 Shiga toxin-producing E. coli, Switzerland, 2000-2009. Emerg Infect Dis 2011, 17(2):180-185.
14. Hermos C.R., Janineh M., Han L.L., McAdam A.J. Shiga toxin-producing E. coli in children: diagnosis and clinical manifestations of O157:H7 and non-O157:H7 infection. J Clin Microbiol 2011, 49(3):955-959.
15. Frank C., Werber D., Cramer J.P., Askar M., Faber M., Heiden M.A., et al. Epidemic Profile of shiga-toxin-producing E. coli O104:H4 outbreak in Germany - preliminary report. N Engl J Med 2011.
16. Jangi S., Lamont J.T. Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. J Pediatr Gastroenterol Nutr 2010, 51(1):2-7.
17. Rousseau C., Levenez F., Fouqueray C., Dore J., Collignon A., Lepage P. Clostridium difficile colonization in early infancy is accompanied by changes in intestinal microbiota composition. J Clin Microbiol 2011, 49(3):858-865.
18. Haque R., Mondal D., Duggal P., Kabir M., Roy S., Farr B.M., et al. Entameba histolytica infection in children and protection from subsequent amebiasis. Infect Immun 2006, 74(2):904-909.
19. Siegal D.S., Hamid N., Cunha B.A. Cytomegalovirus colitis mimicking ischemic colitis in an immunocompetent host. Heart Lung 2005, 34(4):291-294.
20. Henry F.J. The epidemiologic importance of dysentery in communities. Rev Infect Dis 1991, 13(Suppl. 4):S238-S244.
21. Gillespie I.A., O'Brien S.J., Frost J.A., Tam C., Tompkins D., Neal K.R., et al. Investigating vomiting and/or bloody diarrhoea in Campylobacter jejuni infection. J Med Microbiol 2006, 55(Pt 6):741-746.
22. Scallan E., Jones T.F., Cronquist A., Thomas S., Frenzen P., Hoefer D., et al. Factors associated with seeking medical care and submitting a stool sample in estimating the burden of foodborne illness. Foodborne Pathog Dis 2006, 3(4):432-438.
23. Butler T., Dunn D., Dahms B., Islam M. Causes of death and the histopathologic findings in fatal shigellosis. Pediatr Infect Dis J 1989, 8(11):767-772.
24. Bardhan P., Faruque A.S., Naheed A., Sack D.A. Decrease in shigellosis-related deaths without Shigella spp.-specific interventions, Asia. Emerg Infect Dis 2010, 16(11):1718-1723.
25. Haque R., Mondal D., Shu J., Roy S., Kabir M., Davis A.N., et al. Correlation of interferon-gamma production by peripheral blood mononuclear cells with childhood malnutrition and susceptibility to amebiasis. Am J Trop Med Hyg 2007, 76(2):340-344.
26. Uysal G., Sokmen A., Vidinlisan S. Clinical risk factors for fatal diarrhea in hospitalized children. Indian J Pediatr 2000, 67(5):329-333.
27. Morpeth S.C., Ramadhani H.O., Crump J.A. Invasive non-Typhi Salmonella disease in Africa. Clin Infect Dis 2009, 49(4):606-611.
28. Fernandez-Cruz A., Munoz P., Mohedano R., Valerio M., Marin M., Alcala L., et al. Campylobacter bacteremia: clinical characteristics, incidence, and outcome over 23 years. Medicine (Baltimore) 2010, 89(5):319-330.
29. Adamkiewicz T.V., Berkovitch M., Krishnan C., Polsinelli C., Kermack D., Olivieri N.F. Infection due to Yersinia enterocolitica in a series of patients with beta-thalassemia: incidence and predisposing factors. Clin Infect Dis 1998, 27(6):1362-1366.
30. Brooks J.T., Sowers E.G., Wells J.G., Greene K.D., Griffin P.M., Hoekstra R.M., et al. Non-O157 Shiga toxin-producing E. coli infections in the United States, 1983-2002. J Infect Dis 2005, 192(8):1422-1429.
31. Ethelberg S., Olsen K.E., Scheutz F., Jensen C., Schiellerup P., Enberg J., et al. Virulence factors for hemolytic uremic syndrome, Denmark. Emerg Infect Dis 2004, 10(5):842-847.
32. Bennish M.L., Khan W.A., Begum M., Bridges E.A., Ahmed S., Saha D., et al. Low risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in Bangladesh. Clin Infect Dis 2006, 42(3):356-362.
33. Smith J.L. Campylobacter jejuni infection during pregnancy: long-term consequences of associated bacteremia, Guillain-Barre syndrome, and reactive arthritist. J Food Prot 2002, 65(4):696-708.
34. Hardy T.A., Blum S., McCombe P.A., Reddel S.W. Guillain-barre syndrome: modern theories of etiology. Curr Allergy Asthma Rep 2011, 11(3):197-204.
35. Townes J.M. Reactive arthritis after enteric infections in the United States: the problem of definition. Clin Infect Dis 2010, 50(2):247-254.
36. Pope J.E., Krizova A., Garg A.X., Thiessen-Philbrook H., Ouimet J.M. Campylobacter reactive arthritis: a systematic review. Semin Arthritis Rheum 2007.
37. Thornley J.P., Jenkins D., Neal K., Wright T., Brough J., Spiller R.C. Relationship of Campylobacter toxigenicity in vitro to the development of postinfectious irritable bowel syndrome. J Infect Dis 2001, 184(5):606-609.
38. Marshall J.K., Thabane M., Garg A.X., Clark W.F., Moayyedi P., Collins S.M. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut 2010, 59(5):605-611.
39. Santi-Rocca J., Rigothier M.C., Guillen N. Host-microbe interactions and defense mechanisms in the development of amoebic liver abscesses. Clin Microbiol Rev 2009, 22(1):65-75. [Table of Contents].
40. Aly S.M., El-Zawawy L.A., Said D.E., Fathy F.M., Mohamed O.N. The utility of lactoferrin in differentiating parasitic from bacterial infections. J Egypt Soc Parasitol 2005 Dec, 35(3 Suppl.):1149-1162.
41. van Langenberg D.R., Gearry R.B., Wong H.L., Ward M., Gibson P.R. The potential value of faecal lactoferrin as a screening test in hospitalized patients with diarrhoea. Intern Med J 2010, 40(12):819-827.
42. Harris J.C., DuPont H.L., Hornick R.B. Fecal leukocytes in diarrheal illness. Ann Intern Med 1972, 76(5):697-703.
43. Gould L.H., Bopp C., Strockbine N., Atkinson R., Baselski V., Body B., et al. Recommendations for diagnosis of shiga toxin-producing E. coli infections by clinical laboratories. MMWR Recomm Rep 2009, 58(RR-12):1-14.
44. Hunt J.M. Shiga toxin-producing E. coli (STEC). Clin Lab Med 2010, 30(1):21-45.
45. Gerner-Smidt P., Hise K., Kincaid J., Hunter S., Rolando S., Hyytia-Trees E., et al. PulseNet USA: a five-year update. Foodborne Pathog Dis 2006, 3(1):9-19.
46. Mead P.S., Griffin P.M. E. coli O157:H7. Lancet 1998, 352(9135):1207-1212.
47. DuPont H.L. Azithromycin for the self-treatment of traveler's diarrhea. Clin Infect Dis 2007, 44(3):347-349.
48. DuPont H.L., Hornick R.B. Adverse effect of lomotil therapy in shigellosis. Jama 1973, 226(13):1525-1528.
49. Murphy G.S., Bodhidatta L., Echeverria P., Tansuphaswadikul S., Hoge C.W., Imlarp S., et al. Ciprofloxacin and loperamide in the treatment of bacillary dysentery. Ann Intern Med 1993, 118(8):582-586.
50. Panos G.Z., Betsi G.I., Falagas M.E. Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with E. coli O157:H7 infection?. Aliment Pharmacol Ther 2006, 24(5):731-742.
51. Tarr P.I. Shiga toxin-associated hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: distinct mechanisms of pathogenesis. Kidney Int Suppl 2009, 112:S29-S32.
52. Lopez E.L., Contrini M.M., Glatstein E., Gonzalez Ayala S., Santoro R., Allende D., et al. Safety and pharmacokinetics of urtoxazumab, a humanized monoclonal antibody, against Shiga-like toxin 2 in healthy adults and in pediatric patients infected with Shiga-like toxin-producing E. coli. Antimicrob Agents Chemother 2010, 54(1):239-243.
53. Nandy S., Mitra U., Rajendran K., Dutta P., Dutta S. Subtype prevalence, plasmid profiles and growing fluoroquinolone resistance in Shigella from Kolkata, India (2001-2007): a hospital-based study. Trop Med Int Health 2010, 15(12):1499-1507.
54. Sivapalasingam S., Nelson J.M., Joyce K., Hoekstra M., Angulo F.J., Mintz E.D. High prevalence of antimicrobial resistance among Shigella isolates in the United states tested by the national antimicrobial resistance monitoring system from 1999 to 2002. Antimicrob Agents Chemother 2006, 50(1):49-54.
55. Tribble D.R., Sanders J.W., Pang L.W., Mason C., Pitarangsi C., Baqar S., et al. Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen. Clin Infect Dis 2007, 44(3):338-346.
56. Howie R.L., Folster J.P., Bowen A., Barzilay E.J., Whichard J.M. Reduced azithromycin susceptibility in Shigella sonnei, United States. Microb Drug Resist 2010, 16(4):245-248.
57. Garey K.W., Sethi S., Yadav Y., DuPont H.L. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect 2008, 70(4):298-304.
58. Ochoa T.J., Chen J., Walker C.M., Gonzales E., Cleary T.G. Rifaximin does not induce toxin production or phage-mediated lysis of Shiga toxin-producing E. coli. Antimicrob Agents Chemother 2007, 51(8):2837-2841.
59. Ohara T., Kojio S., Taneike I., Nakagawa S., Gondaira F., Tamura Y., et al. Effects of azithromycin on shiga toxin production by E. coli and subsequent host inflammatory response. Antimicrob Agents Chemother 2002, 46(11):3478-3483.
60. Scallan E., Hoekstra R.M., Angulo F.J., Tauxe R.V., Widdowson M.A., Roy S.L., et al. Foodborne illness acquired in the United States - major pathogens. Emerg Infect Dis 2011, 17(1):7-15.
61. Stanley S.L. Amoebiasis. Lancet 2003, 361(9362):1025-1034.
62. Abu-Elyazeed R.R., Wierzba T.F., Frenck R.W., Putnam S.D., Rao M.R., Savarino S.J., et al. Epidemiology of Shigella-associated diarrhea in rural Egyptian children. Am J Trop Med Hyg 2004, 71(3):367-372.
63. Jafari F., Garcia-Gil L.J., Salmanzadeh-Ahrabi S., Shokrzadeh L., Aslani M.M., Pourhoseingholi M.A., et al. Diagnosis and prevalence of enteropathogenic bacteria in children less than 5 years of age with acute diarrhea in Tehran children's hospitals. J Infect 2009, 58(1):21-27.
64. Karacan C., Tavil B., Topal Y., Zorlu P., Tayman C. Evaluation of shigellosis in a Turkish children's hospital. Pediatr Int 2007, 49(5):589-592.
65. Mandomando I., Sigauque B., Valles X., Espasa M., Sanz S., Sacarlal J., et al. Epidemiology and clinical presentation of shigellosis in children less than five years of age in rural Mozambique. Pediatr Infect Dis J 2007, 26(11):1059-1061.
66. Ranjbar R., Hosseini M.J., Kaffashian A.R., Farshad S. An outbreak of shigellosis due to Shigella flexneri serotype 3a in a prison in Iran. Arch Iran Med 2010, 13(5):413-416.
67. von Seidlein L., Kim D.R., Ali M., Lee H., Wang X., Thiem V.D., et al. A Multicentre study of Shigella diarrhoea in Six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Med 2006, 3(9).
68. Wang X.Y., Du L., Von Seidlein L., Xu Z.Y., Zhang Y.L., Hao Z.Y., et al. Occurrence of shigellosis in the young and elderly in rural China: results of a 12-month population-based surveillance study. Am J Trop Med Hyg 2005, 73(2):416-422.
69. Wu C.H., Huang L.T., Huang I.F., Liu J.W., Chen J.B., Liang C.D., et al. Acute non-outbreak shigellosis: ten years experience in southern Taiwan. Chang Gung Med J 2009, 32(1):59-65.
70. Youssef M., Shurman A., Bougnoux M., Rawashdeh M., Bretagne S., Strockbine N. Bacterial, viral and parasitic enteric pathogens associated with acute diarrhea in hospitalized children from northern Jordan. FEMS Immunol Med Microbiol 2000, 28(3):257-263.
71. Gaynor K., Park S.Y., Kanenaka R., Colindres R., Mintz E., Ram P.K., et al. International foodborne outbreak of Shigella sonnei infection in airline passengers. Epidemiol Infect 2009, 137(3):335-341.
72. Olesen B., Neimann J., Bottiger B., Ethelberg S., Schiellerup P., Jensen C., et al. Etiology of diarrhea in young children in Denmark: a case-control study. J Clin Microbiol 2005, 43(8):3636-3641.
73. Reller M.E., Nelson J.M., Molbak K., Ackman D.M., Schoonmaker-Bopp D.J., Root T.P., et al. A large, multiple-restaurant outbreak of infection with Shigella flexneri serotype 2a traced to tomatoes. Clin Infect Dis 2006, 42(2):163-169.
74. Svenungsson B., Lagergren A., Ekwall E., Evengard B., Hedlund K.O., Karnell A., et al. Enteropathogens in adult patients with diarrhea and healthy control subjects: a 1-year prospective study in a Swedish clinic for infectious diseases. Clin Infect Dis 2000, 30(5):770-778.
75. Chan S.S., Ng K.C., Lyon D.J., Cheung W.L., Cheng A.F., Rainer T.H. Acute bacterial gastroenteritis: a study of adult patients with positive stool cultures treated in the emergency department. Emerg Med J 2003, 20(4):335-338.
76. Multistate outbreak of human Salmonella infections associated with exposure to turtles - United States, 2007-2008. MMWR Morb Mortal Wkly Rep. 2008 Jan 25;57(3):69-72.
77. Essers B., Burnens A.P., Lanfranchini F.M., Somaruga S.G., von Vigier R.O., Schaad U.B., et al. Acute community-acquired diarrhea requiring hospital admission in Swiss children. Clin Infect Dis 2000, 31(1):192-196.
78. Yang J.R., Wu H.S., Chiang C.S., Mu J.J. Pediatric campylobacteriosis in northern Taiwan from 2003 to 2005. BMC Infect Dis 2008, 8:151.
79. Gallay A., Bousquet V., Siret V., Prouzet-Mauleon V., Valk H., Vaillant V., et al. Risk factors for acquiring sporadic Campylobacter infection in France: results from a national case-control study. J Infect Dis 2008, 197(10):1477-1484.
80. Richardson G., Thomas D.R., Smith R.M., Nehaul L., Ribeiro C.D., Brown A.G., et al. A community outbreak of Campylobacter jejuni infection from a chlorinated public water supply. Epidemiol Infect 2007, 135(7):1151-1158.
81. Laboratory-confirmed non-O157 Shiga toxin-producing E. coli - Connecticut, 2000-2005. MMWR Morb Mortal Wkly Rep. 2007 Jan 19;56(2):29-31.
82. Friesema I., Sigmundsdottir G., van der Zwaluw K., Heuvelink A., Schimmer B., de Jager C., et al. An international outbreak of Shiga toxin-producing E. coli O157 infection due to lettuce, September-October 2007. Euro Surveill 2008, 11(50):13.
83. Grant J., Wendelboe A.M., Wendel A., Jepson B., Torres P., Smelser C., et al. Spinach-associated E. coli O157:H7 outbreak, Utah and New Mexico, 2006. Emerg Infect Dis 2008, 14(10):1633-1636.
84. Guh A., Phan Q., Nelson R., Purviance K., Milardo E., Kinney S., et al. Outbreak of E. coli O157 associated with raw milk, Connecticut, 2008. Clin Infect Dis 2010, 51(12):1411-1417.
85. McPherson M., Lalor K., Combs B., Raupach J., Stafford R., Kirk M.D. Serogroup-specific risk factors for Shiga toxin-producing E. coli infection in Australia. Clin Infect Dis 2009, 49(2):249-256.
86. Rivero M.A., Passucci J.A., Rodriguez E.M., Parma A.E. Role and clinical course of verotoxigenic E. coli infections in childhood acute diarrhoea in Argentina. J Med Microbiol 2010, 59(Pt 3):345-352.
87. Watanabe K., Murayama A., Kogure N., Kawase M., Kimura Y. An outbreak of food poisoning due to enterohemorrhagic E. coli O157 in Niigata. Japan Jpn J Infect Dis 2010, 63(2):146-147.
88. Wendel A.M., Johnson D.H., Sharapov U., Grant J., Archer J.R., Monson T., et al. Multistate outbreak of E. coli O157:H7 infection associated with consumption of packaged spinach, August-September 2006: the Wisconsin investigation. Clin Infect Dis 2009, 48(8):1079-1086.
89. Leotta G.A., Miliwebsky E.S., Chinen I., Espinosa E.M., Azzopardi K., Tennant S.M., et al. Characterisation of Shiga toxin-producing E. coli O157 strains isolated from humans in Argentina, Australia and New Zealand. BMC Microbiol 2008, 8:46.
90. McAnulty J.M., Fleming D.W., Gonzalez A.H. A community-wide outbreak of cryptosporidiosis associated with swimming at a wave pool. JAMA 1994, 272(20):1597-1600.
91. Gluskin I., Batash D., Shoseyov D., Mor A., Kazak R., Azizi E., et al. A 15-year study of the role of Aeromonas spp. in gastroenteritis in hospitalised children. J Med Microbiol 1992, 37(5):315-318.
92. Khan A.M., Faruque A.S., Hossain M.S., Sattar S., Fuchs G.J., Salam M.A. Plesiomonas shigelloides-associated diarrhoea in Bangladeshi children: a hospital-based surveillance study. J Trop Pediatr 2004, 50(6):354-356.
93. Wong T.Y., Tsui H.Y., So M.K., Lai J.Y., Lai S.T., Tse C.W., et al. Plesiomonas shigelloides infection in Hong Kong: retrospective study of 167 laboratory-confirmed cases. Hong Kong Med J 2000, 6(4):375-380.
94. Ostroff S.M., Kapperud G., Lassen J., Aasen S., Tauxe R.V. Clinical features of sporadic Yersinia enterocolitica infections in Norway. J Infect Dis 1992, 166(4):812-817.
95. Zheng H., Sun Y., Lin S., Mao Z., Jiang B. Yersinia enterocolitica infection in diarrheal patients. Eur J Clin Microbiol Infect Dis 2008, 27(8):741-752.
96. Bauer M.P., Veenendaal D., Verhoef L., Bloembergen P., van Dissel J.T., Kuijper E.J. Clinical and microbiological characteristics of community-onset Clostridium difficile infection in The Netherlands. Clin Microbiol Infect 2009, 15(12):1087-1092.
97. Indra A., Schmid D., Huhulescu S., Hell M., Gattringer R., Hasenberger P., et al. Characterization of clinical Clostridium difficile isolates by PCR ribotyping and detection of toxin genes in Austria, 2006-2007. J Med Microbiol 2008, 57(Pt 6):702-708.
98. Haque R., Mondal D., Kirkpatrick B.D., Akther S., Farr B.M., Sack R.B., et al. Epidemiologic and clinical characteristics of acute diarrhea with emphasis on Entameba histolytica infections in preschool children in an urban slum of Dhaka, Bangladesh. Am J Trop Med Hyg 2003, 69(4):398-405.
99. Memon I.A., Jamal A., Memon H., Parveen N. Intestinal amoebiasis in children and its effect on nutritional status. J Coll Physicians Surg Pak 2009, 19(7):440-443.
100. Tanyuksel M., Yilmaz H., Ulukanligil M., Araz E., Cicek M., Koru O., et al. Comparison of two methods (microscopy and enzyme-linked immunosorbent assay) for the diagnosis of amebiasis. Exp Parasitol 2005, 110(3):322-326.
101. Lin W.R., Su M.Y., Hsu C.M., Ho Y.P., Ngan K.W., Chiu C.T., et al. Clinical and endoscopic features for alimentary tract cytomegalovirus disease: report of 20 cases with gastrointestinal cytomegalovirus disease. Chang Gung Med J 2005, 28(7):476-484.